Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

1.

Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.

Rush AJ, Marangell LB, Sackeim HA, George MS, Brannan SK, Davis SM, Howland R, Kling MA, Rittberg BR, Burke WJ, Rapaport MH, Zajecka J, Nierenberg AA, Husain MM, Ginsberg D, Cooke RG.

Biol Psychiatry. 2005 Sep 1;58(5):347-54.

PMID:
16139580
2.

Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study.

Rush AJ, Sackeim HA, Marangell LB, George MS, Brannan SK, Davis SM, Lavori P, Howland R, Kling MA, Rittberg B, Carpenter L, Ninan P, Moreno F, Schwartz T, Conway C, Burke M, Barry JJ.

Biol Psychiatry. 2005 Sep 1;58(5):355-63.

PMID:
16139581
3.

Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study.

Rush AJ, George MS, Sackeim HA, Marangell LB, Husain MM, Giller C, Nahas Z, Haines S, Simpson RK Jr, Goodman R.

Biol Psychiatry. 2000 Feb 15;47(4):276-86.

PMID:
10686262
4.

A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression.

George MS, Rush AJ, Marangell LB, Sackeim HA, Brannan SK, Davis SM, Howland R, Kling MA, Moreno F, Rittberg B, Dunner D, Schwartz T, Carpenter L, Burke M, Ninan P, Goodnick P.

Biol Psychiatry. 2005 Sep 1;58(5):364-73.

PMID:
16139582
5.

Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes.

Nahas Z, Marangell LB, Husain MM, Rush AJ, Sackeim HA, Lisanby SH, Martinez JM, George MS.

J Clin Psychiatry. 2005 Sep;66(9):1097-104.

PMID:
16187765
6.

A 1-year pilot study of vagus nerve stimulation in treatment-resistant rapid-cycling bipolar disorder.

Marangell LB, Suppes T, Zboyan HA, Prashad SJ, Fischer G, Snow D, Sureddi S, Allen JC.

J Clin Psychiatry. 2008 Feb;69(2):183-9.

PMID:
18211128
7.

Vagus nerve stimulation for depression: efficacy and safety in a European study.

Schlaepfer TE, Frick C, Zobel A, Maier W, Heuser I, Bajbouj M, O'Keane V, Corcoran C, Adolfsson R, Trimble M, Rau H, Hoff HJ, Padberg F, Müller-Siecheneder F, Audenaert K, Van den Abbeele D, Stanga Z, Hasdemir M.

Psychol Med. 2008 May;38(5):651-61. doi: 10.1017/S0033291707001924. Epub 2008 Jan 4. Erratum in: Psychol Med. 2008 Jul;38(7):1067. Matthews, K [removed]; Christmas, D [removed].

PMID:
18177525
8.

Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.

Carpenter LL, Moreno FA, Kling MA, Anderson GM, Regenold WT, Labiner DM, Price LH.

Biol Psychiatry. 2004 Sep 15;56(6):418-26.

PMID:
15364040
9.

Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome.

Sackeim HA, Rush AJ, George MS, Marangell LB, Husain MM, Nahas Z, Johnson CR, Seidman S, Giller C, Haines S, Simpson RK Jr, Goodman RR.

Neuropsychopharmacology. 2001 Nov;25(5):713-28.

10.

Effectiveness and safety of vagus nerve stimulation for severe treatment-resistant major depression in clinical practice after FDA approval: outcomes at 1 year.

Cristancho P, Cristancho MA, Baltuch GH, Thase ME, O'Reardon JP.

J Clin Psychiatry. 2011 Oct;72(10):1376-82. doi: 10.4088/JCP.09m05888blu.

PMID:
21295002
11.

Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes.

Marangell LB, Rush AJ, George MS, Sackeim HA, Johnson CR, Husain MM, Nahas Z, Lisanby SH.

Biol Psychiatry. 2002 Feb 15;51(4):280-7.

PMID:
11958778
12.

Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression.

Dunner DL, Rush AJ, Russell JM, Burke M, Woodard S, Wingard P, Allen J.

J Clin Psychiatry. 2006 May;67(5):688-95.

PMID:
16841617
13.

Clinical issues in considering vagus nerve stimulation for treatment-resistant depression.

Rush AJ, Siefert SE.

Exp Neurol. 2009 Sep;219(1):36-43. doi: 10.1016/j.expneurol.2009.04.015. Epub 2009 May 3. Review.

PMID:
19397908
14.

Cervical vagus nerve stimulation for treatment-resistant depression.

Carpenter LL, Friehs GM, Price LH.

Neurosurg Clin N Am. 2003 Apr;14(2):275-82. Review.

PMID:
12856494
15.
16.

A controlled trial of daily left prefrontal cortex TMS for treating depression.

George MS, Nahas Z, Molloy M, Speer AM, Oliver NC, Li XB, Arana GW, Risch SC, Ballenger JC.

Biol Psychiatry. 2000 Nov 15;48(10):962-70.

PMID:
11082469
17.

A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.

Patkar AA, Masand PS, Pae CU, Peindl K, Hooper-Wood C, Mannelli P, Ciccone P.

J Clin Psychopharmacol. 2006 Dec;26(6):653-6.

PMID:
17110825
18.

A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.

Fava M, Rush AJ, Wisniewski SR, Nierenberg AA, Alpert JE, McGrath PJ, Thase ME, Warden D, Biggs M, Luther JF, Niederehe G, Ritz L, Trivedi MH.

Am J Psychiatry. 2006 Jul;163(7):1161-72.

PMID:
16816220
19.

Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial.

O'Reardon JP, Solvason HB, Janicak PG, Sampson S, Isenberg KE, Nahas Z, McDonald WM, Avery D, Fitzgerald PB, Loo C, Demitrack MA, George MS, Sackeim HA.

Biol Psychiatry. 2007 Dec 1;62(11):1208-16. Epub 2007 Jun 14.

PMID:
17573044
20.

Supplemental Content

Support Center